Atrophy, aplasia, and hypoplasia

22,686views

Atrophy, aplasia, and hypoplasia

Watch later

Watch later

Inflammation
Wound healing
Shock: Clinical
Type II hypersensitivity
Type I hypersensitivity
Type IV hypersensitivity
Type III hypersensitivity
Cystic fibrosis
Muscular dystrophy
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Respiratory alkalosis
Metabolic alkalosis
Hypoxia
Oncogenes and tumor suppressor genes
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Metaplasia and dysplasia
Ischemia
Free radicals and cellular injury
Myocardial infarction
Hypertension
Cushing syndrome
Pheochromocytoma
Coarctation of the aorta
Hypotension
Chronic venous insufficiency
Deep vein thrombosis
Shock
Tetralogy of Fallot
Persistent truncus arteriosus
Ventricular septal defect
Atrial septal defect
Patent ductus arteriosus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Aortic valve disease
Pulmonary valve disease
Tricuspid valve disease
Mitral valve disease
Cor pulmonale
Heart failure
Endocarditis
Myocarditis
Rheumatic heart disease
Pericarditis and pericardial effusion
Atrioventricular block
Bundle branch block
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Premature atrial contraction
Atrial flutter
Atrial fibrillation
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Coronary artery disease: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Cardiomyopathies: Pathology review
Supraventricular arrhythmias: Pathology review
Heart failure: Pathology review
Valvular heart disease: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Pericardial disease: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Endocarditis: Pathology review
Hyperthyroidism
Hypothyroidism
Hyperparathyroidism
Hypercalcemia
Hypoparathyroidism
Hypocalcemia
Diabetes mellitus
Diabetic nephropathy
Hypopituitarism
Hyperpituitarism
Diabetes insipidus
Hyperthyroidism: Pathology review
Adrenal insufficiency: Pathology review
Hypothyroidism: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Hypopituitarism: Pathology review
Diabetic retinopathy
Peptic ulcer
Ulcerative colitis
Crohn disease
Bowel obstruction
Gallstone ileus
Abdominal hernias
Inguinal hernia
Small bowel ischemia and infarction
Diverticulosis and diverticulitis
Appendicitis
Jaundice
Cirrhosis
Portal hypertension
Gallstones
Acute cholecystitis
Chronic cholecystitis
Acute pancreatitis
Chronic pancreatitis
Malabsorption syndromes: Pathology review
Inflammatory bowel disease: Pathology review
Esophageal disorders: Pathology review
Diverticular disease: Pathology review
Pancreatitis: Pathology review
Jaundice: Pathology review
Cirrhosis: Pathology review
Iron deficiency anemia
Sideroblastic anemia
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Aplastic anemia
Megaloblastic anemia
Thrombotic thrombocytopenic purpura
Disseminated intravascular coagulation
Chronic leukemia
Acute leukemia
Non-Hodgkin lymphoma
Hodgkin lymphoma
Polycythemia vera (NORD)
Mastocytosis (NORD)
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Leukemias: Pathology review
Systemic lupus erythematosus
Poststreptococcal glomerulonephritis
DiGeorge syndrome
Hereditary angioedema
Complement deficiency
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Osteoporosis
Spina bifida
Intracerebral hemorrhage
Subarachnoid hemorrhage
Epidural hematoma
Subdural hematoma
Alzheimer disease
Parkinson disease
Hypermagnesemia
Hyperkalemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypernatremia
Minimal change disease
Focal segmental glomerulosclerosis (NORD)
Membranoproliferative glomerulonephritis
IgA nephropathy (NORD)
Rapidly progressive glomerulonephritis
Alport syndrome
Kidney stones
Acute pyelonephritis
Chronic pyelonephritis
Chronic kidney disease
Renal artery stenosis
Nephritic syndromes: Pathology review
Renal failure: Pathology review
Nephrotic syndromes: Pathology review
Acute respiratory distress syndrome
Asthma
Emphysema
Chronic bronchitis
Bronchiectasis
Restrictive lung diseases
Sarcoidosis
Pneumonia
Pneumothorax
Pleural effusion
Pulmonary embolism
Pulmonary hypertension
Pulmonary edema
Respiratory distress syndrome: Pathology review
Pneumonia: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review

Transcript

Watch video only

Content Reviewers

Growing is an important part of living.

In fact, everything from an individual muscle cell, to a baby blue whale - strives to grow, in order to live and perhaps replicate or reproduce.

Sometimes, however, growth fails to occur, or even reverts back, and we call that atrophy, aplasia, or hypoplasia, depending on the situation.

Let’s break down these words. Atrophy, “a” means “no”, and “trophy”, means nourishment. So, atrophy means “no nourishment”.

Aplasia, “a” means “no” and “plasia” means development. So aplasia means “no development”, and “hypo” means “under” so hypoplasia is “under formation”.

In a nutshell, atrophy is the reduction in size of a cell, organ, or tissue, after it has attained its normal, matured growth.

This happens either through decrease in cell number or decrease in cell size.

Decrease in cell number most commonly happens due to apoptosis, which is controlled type of cell death - a bit like cellular suicide.

An example would be weight loss. In the first few weeks to months of eating healthy and losing weight, the fat cells or adipocytes get smaller but are ready to fill up again with fat.

Over months to years of eating healthy, however, the adipocytes undergo apoptosis - and at that point it’s a bit more difficult to gain back the weight.

Decrease in cell size, however, is a bit more complex.

Usually, the first step is the loss of nerve or hormonal supply, both of which provide nourishment to cells.

Then there’s something called the ubiquitin proteasome pathway.

You see, cells have a cytoskeleton, which is a framework of various filaments that keep the cell propped up.

As cells start getting less nourishment, those filaments get “tagged” for demolition with a protein called ubiquitin.

Ubiquitin proteins start to attach to one another - a process known as polyubiquitination.

And then an intracellular protein complex called a proteasome comes in to destroy all polyubiquitinated filaments, causing the cell to decrease in size.

Some organelles can also be tagged with ubiquitin; and when that happens, a bubble of phospholipid bilayer membrane forms around the organelle, creating a vacuole.

Next, lysosomal vesicles which are filled with degradative enzymes, fuse with the vacuole; destroying the unfortunate organelle. Like being sent off to the firing squad.

An example is muscle atrophy.

Anytime there’s long-standing disuse of muscles, like extended bedrest, zero gravity, or during long study sessions, there can be a loss of muscle mass and strength.

Key Takeaways

Atrophy, aplasia, and hypoplasia all refer to degeneration or poor growth of cells and tissues. Atrophy refers to the reduction in size of a tissue, or organ, after it had been normally formed and attained its normal growth. With aplasia there is a complete congenital lack of the cells, tissue or organ, whereas in hypoplasia, precursor cells are present, but they do not develop into their intended organs during embryogenesis. All three conditions can be caused by a variety of factors, including disease, injury, or genetic abnormalities

Sources

  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "Mergla K <sup>+</sup> channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway" The FASEB Journal (2006)
  7. "Cancer cachexia" International Journal of Cardiology (2002)
  8. "Nutritional Considerations in Preventing Muscle Atrophy" Advances in Experimental Medicine and Biology (2018)
  9. "Genetic causes of optic nerve hypoplasia" Journal of Medical Genetics (2017)